How effective is Tezspire for EGPA, and what are its side effects?

Question

Hi doctor,

I have eosinophilic granulomatosis with polyangiitis (EGPA) and experience symptoms, including asthma, sinus issues, and skin rashes. My doctor mentioned Tezspire as a potential treatment. I would like to understand how Tezspire works in autoimmune vasculitis conditions like EGPA. Is it more effective than other biologic therapies commonly used for EGPA? How soon can I expect symptom relief, particularly for asthma and skin involvement? Additionally, what are the potential long-term side effects of this medication? Should I continue my current immunosuppressive medications while taking Tezspire? Please help.

Thank you.

Answer 1

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

Tezspire (Tezepelumab) targets thymic stromal lymphopoietin (TSLP), a key driver of eosinophilic inflammation, and may help manage asthma symptoms in eosinophilic granulomatosis with polyangiitis (EGPA). However, it is not specifically approved for the treatment of vasculitis. Other biologic therapies, such as Nucala (Mepolizumab) or Rituxan (Rituximab), have more established use in treating EGPA. The timeline for symptom relief varies from person to person, and the long-term effects of Tezspire are still being studied. It is important to discuss with your doctor whether you should continue your current immunosuppressive medications while taking Tezspire.

I hope this helps.

Kindly revert so I can assist you further.

Thank you.